Carmell (CTCX) Competitors $5.70 +3.06 (+115.50%) As of 07/15/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CTCX vs. CV, MGRM, SKIN, CVRX, TLSI, INGN, SGHT, PROF, ELMD, and LNSRShould you be buying Carmell stock or one of its competitors? The main competitors of Carmell include CapsoVision (CV), Monogram Orthopaedics (MGRM), Beauty Health (SKIN), CVRx (CVRX), TriSalus Life Sciences (TLSI), Inogen (INGN), Sight Sciences (SGHT), Profound Medical (PROF), Electromed (ELMD), and LENSAR (LNSR). These companies are all part of the "medical equipment" industry. Carmell vs. Its Competitors CapsoVision Monogram Orthopaedics Beauty Health CVRx TriSalus Life Sciences Inogen Sight Sciences Profound Medical Electromed LENSAR CapsoVision (NASDAQ:CV) and Carmell (NASDAQ:CTCX) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk and dividends. Do insiders & institutionals have more ownership in CV or CTCX? 24.2% of Carmell shares are owned by institutional investors. 29.0% of Carmell shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media refer more to CV or CTCX? In the previous week, CapsoVision had 2 more articles in the media than Carmell. MarketBeat recorded 2 mentions for CapsoVision and 0 mentions for Carmell. Carmell's average media sentiment score of 0.00 beat CapsoVision's score of -0.50 indicating that Carmell is being referred to more favorably in the news media. Company Overall Sentiment CapsoVision Negative Carmell Neutral Is CV or CTCX more profitable? CapsoVision's return on equity of 0.00% beat Carmell's return on equity.Company Net Margins Return on Equity Return on Assets CapsoVisionN/A N/A N/A Carmell N/A -217.50%-50.22% Which has stronger valuation & earnings, CV or CTCX? CapsoVision has higher earnings, but lower revenue than Carmell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCapsoVisionN/AN/AN/AN/AN/ACarmell$32.84K3,628.57-$15.44MN/AN/A SummaryCarmell beats CapsoVision on 4 of the 7 factors compared between the two stocks. Get Carmell News Delivered to You Automatically Sign up to receive the latest news and ratings for CTCX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CTCX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CTCX vs. The Competition Export to ExcelMetricCarmellSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$119.16M$65.14M$5.51B$9.31BDividend YieldN/AN/A4.25%4.09%P/E RatioN/A5.0528.1219.69Price / Sales3,628.57193.85439.46100.25Price / CashN/A18.4135.5357.53Price / Book5.336.988.235.67Net Income-$15.44M-$25.02M$3.23B$257.51M7 Day Performance142.55%5.15%-0.52%-0.16%1 Month Performance134.57%1.16%6.71%9.89%1 Year Performance307.14%37.32%27.10%15.08% Carmell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CTCXCarmellN/A$5.70+115.5%N/A+275.0%$119.16M$32.84K0.0014Gap UpHigh Trading VolumeCVCapsoVisionN/A$4.59+5.0%N/AN/A$212.70MN/A0.0090MGRMMonogram Orthopaedics1.0437 of 5 stars$5.90+0.5%$5.40-8.5%+161.5%$210.56MN/A-13.1128High Trading VolumeSKINBeauty Health0.2821 of 5 stars$1.64-12.3%$1.42-13.6%-21.8%$206.63M$322.47M-4.001,030Positive NewsCVRXCVRx3.0553 of 5 stars$7.10-3.4%$14.50+104.2%-14.7%$185.12M$52.87M-3.26160News CoveragePositive NewsTLSITriSalus Life Sciences2.9994 of 5 stars$4.74-4.8%$10.75+126.8%-12.8%$179.36M$32.14M-4.23106INGNInogen4.2565 of 5 stars$6.55-2.4%$11.00+67.9%-32.9%$176.11M$339.96M-5.701,030SGHTSight Sciences1.5783 of 5 stars$3.34-9.7%$3.93+17.8%-57.8%$172.67M$78.11M-3.41210Analyst ForecastPROFProfound Medical2.8884 of 5 stars$5.70-0.9%$11.50+101.8%-40.6%$171.29M$10.68M-4.67150ELMDElectromed0.8508 of 5 stars$18.24-5.5%$38.00+108.3%+20.1%$152.96M$61.44M24.32160LNSRLENSAR1.2872 of 5 stars$12.90flat$15.00+16.3%+156.6%$152.09M$53.49M-2.66110 Related Companies and Tools Related Companies CV Alternatives MGRM Alternatives SKIN Alternatives CVRX Alternatives TLSI Alternatives INGN Alternatives SGHT Alternatives PROF Alternatives ELMD Alternatives LNSR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CTCX) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carmell Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Carmell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
